News

On November 22, 2021, a General Assembly of the Latvian Medicines Verification Organisation (LZVO) was held, where the strategy and budget for 2022 were approved, as well as a report on the most significant work done this year was presented.

In order for patients to receive only safe medicines, pharmacies and health care institutions in the first nine months of 2021 have checked in the verification system and handed over 19 million packages of medicines to residents in Latvia.

Inese Erdmane, Chairwoman of the Board at LZVO share insights of the Latvian medicine’s verification process with Dansk Medicin Verifikation Organisation Newsletter.

EMVO informs, that prototype and first phase of development for AMS HUB has been completed. AMS HUB solution is currently under system test by provider (started at September 17). Next milestone would be production pilot phase – October 4.

To guarantee the safety and authenticity of medicines to patients, in the first half of 2021, 12 million packages of medicines were verified in the system and reached consumers in Latvia, according to the Latvian Medicines Verification Organization (LZVO) data

The Latvian Medicines Verification System (LZVS) has successfully passed all compatibility tests so that the Latvian national system is prepared for European Medicines Verification System (EU Hub) updates / system release 1.9. LZVS is ready to work without interruption and restriction